Gender disparities in HIV infection among persons who inject drugs in Central Asia

A systematic review and meta-analysis

Don Des Jarlais, Azizbek Boltaev, Jonathan Feelemyer, Heidi Bramson, Kamyar Arasteh, Benjamin W. Phillips, Holly Hagan

Research output: Contribution to journalArticle

Abstract

Objective: Disparities in HIV infection, with females having higher rates of HIV infection than males, have been noted among persons who inject drugs (PWID) in many countries. We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide. Methods: A systematic review and meta-analyses were conducted for studies reporting HIV prevalence by gender among PWID. To be included in the analyses, reports had to contain (1) samples of PWID from Central Asia, (2) HIV data based on laboratory testing, (3) HIV prevalence reported for males and females, and (4) samples that were not recruited on the basis of HIV status. Results: Data were abstracted from 11 studies in 5 countries in Central Asia: China, Kazakhstan, Russia, Tajikistan, and Uzbekistan; the total sample size was 12,225. The mean weighted OR for HIV prevalence among females to males was 0.913 (95% CI 0.07, 1.26), with high heterogeneity among studies (I2=70.0%) and a possible publication bias among studies with small sample sizes (Eggers test=-1.81, 95% CI -5.18, 0.54). Conclusions: The non-significant higher HIV prevalence among male PWID in Central Asia contrasts with the worldwide findings which show slightly higher HIV prevalence among female PWID. This may reflect the relative recency of the HIV epidemics in Central Asia. The findings also suggest there may be factors that protect female PWID from HIV in some settings. Further examination of transmission dynamics in Central Asia is necessary to better understand the HIV epidemic among PWID.

Original languageEnglish (US)
JournalDrug and Alcohol Dependence
Volume132
Issue numberSUPPL1
DOIs
StatePublished - Nov 2013

Fingerprint

Central Asia
HIV Infections
Meta-Analysis
HIV
Pharmaceutical Preparations
Sample Size
Tajikistan
Uzbekistan
Kazakhstan
Publication Bias
HIV-2
Russia
China

Keywords

  • Central Asia
  • Gender
  • HIV
  • People who inject drugs (PWID)
  • Prevalence

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Gender disparities in HIV infection among persons who inject drugs in Central Asia : A systematic review and meta-analysis. / Des Jarlais, Don; Boltaev, Azizbek; Feelemyer, Jonathan; Bramson, Heidi; Arasteh, Kamyar; Phillips, Benjamin W.; Hagan, Holly.

In: Drug and Alcohol Dependence, Vol. 132, No. SUPPL1, 11.2013.

Research output: Contribution to journalArticle

@article{1455770edef24818bdf6577c275ea9de,
title = "Gender disparities in HIV infection among persons who inject drugs in Central Asia: A systematic review and meta-analysis",
abstract = "Objective: Disparities in HIV infection, with females having higher rates of HIV infection than males, have been noted among persons who inject drugs (PWID) in many countries. We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide. Methods: A systematic review and meta-analyses were conducted for studies reporting HIV prevalence by gender among PWID. To be included in the analyses, reports had to contain (1) samples of PWID from Central Asia, (2) HIV data based on laboratory testing, (3) HIV prevalence reported for males and females, and (4) samples that were not recruited on the basis of HIV status. Results: Data were abstracted from 11 studies in 5 countries in Central Asia: China, Kazakhstan, Russia, Tajikistan, and Uzbekistan; the total sample size was 12,225. The mean weighted OR for HIV prevalence among females to males was 0.913 (95{\%} CI 0.07, 1.26), with high heterogeneity among studies (I2=70.0{\%}) and a possible publication bias among studies with small sample sizes (Eggers test=-1.81, 95{\%} CI -5.18, 0.54). Conclusions: The non-significant higher HIV prevalence among male PWID in Central Asia contrasts with the worldwide findings which show slightly higher HIV prevalence among female PWID. This may reflect the relative recency of the HIV epidemics in Central Asia. The findings also suggest there may be factors that protect female PWID from HIV in some settings. Further examination of transmission dynamics in Central Asia is necessary to better understand the HIV epidemic among PWID.",
keywords = "Central Asia, Gender, HIV, People who inject drugs (PWID), Prevalence",
author = "{Des Jarlais}, Don and Azizbek Boltaev and Jonathan Feelemyer and Heidi Bramson and Kamyar Arasteh and Phillips, {Benjamin W.} and Holly Hagan",
year = "2013",
month = "11",
doi = "10.1016/j.drugalcdep.2013.06.028",
language = "English (US)",
volume = "132",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "SUPPL1",

}

TY - JOUR

T1 - Gender disparities in HIV infection among persons who inject drugs in Central Asia

T2 - A systematic review and meta-analysis

AU - Des Jarlais, Don

AU - Boltaev, Azizbek

AU - Feelemyer, Jonathan

AU - Bramson, Heidi

AU - Arasteh, Kamyar

AU - Phillips, Benjamin W.

AU - Hagan, Holly

PY - 2013/11

Y1 - 2013/11

N2 - Objective: Disparities in HIV infection, with females having higher rates of HIV infection than males, have been noted among persons who inject drugs (PWID) in many countries. We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide. Methods: A systematic review and meta-analyses were conducted for studies reporting HIV prevalence by gender among PWID. To be included in the analyses, reports had to contain (1) samples of PWID from Central Asia, (2) HIV data based on laboratory testing, (3) HIV prevalence reported for males and females, and (4) samples that were not recruited on the basis of HIV status. Results: Data were abstracted from 11 studies in 5 countries in Central Asia: China, Kazakhstan, Russia, Tajikistan, and Uzbekistan; the total sample size was 12,225. The mean weighted OR for HIV prevalence among females to males was 0.913 (95% CI 0.07, 1.26), with high heterogeneity among studies (I2=70.0%) and a possible publication bias among studies with small sample sizes (Eggers test=-1.81, 95% CI -5.18, 0.54). Conclusions: The non-significant higher HIV prevalence among male PWID in Central Asia contrasts with the worldwide findings which show slightly higher HIV prevalence among female PWID. This may reflect the relative recency of the HIV epidemics in Central Asia. The findings also suggest there may be factors that protect female PWID from HIV in some settings. Further examination of transmission dynamics in Central Asia is necessary to better understand the HIV epidemic among PWID.

AB - Objective: Disparities in HIV infection, with females having higher rates of HIV infection than males, have been noted among persons who inject drugs (PWID) in many countries. We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide. Methods: A systematic review and meta-analyses were conducted for studies reporting HIV prevalence by gender among PWID. To be included in the analyses, reports had to contain (1) samples of PWID from Central Asia, (2) HIV data based on laboratory testing, (3) HIV prevalence reported for males and females, and (4) samples that were not recruited on the basis of HIV status. Results: Data were abstracted from 11 studies in 5 countries in Central Asia: China, Kazakhstan, Russia, Tajikistan, and Uzbekistan; the total sample size was 12,225. The mean weighted OR for HIV prevalence among females to males was 0.913 (95% CI 0.07, 1.26), with high heterogeneity among studies (I2=70.0%) and a possible publication bias among studies with small sample sizes (Eggers test=-1.81, 95% CI -5.18, 0.54). Conclusions: The non-significant higher HIV prevalence among male PWID in Central Asia contrasts with the worldwide findings which show slightly higher HIV prevalence among female PWID. This may reflect the relative recency of the HIV epidemics in Central Asia. The findings also suggest there may be factors that protect female PWID from HIV in some settings. Further examination of transmission dynamics in Central Asia is necessary to better understand the HIV epidemic among PWID.

KW - Central Asia

KW - Gender

KW - HIV

KW - People who inject drugs (PWID)

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84887197872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887197872&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2013.06.028

DO - 10.1016/j.drugalcdep.2013.06.028

M3 - Article

VL - 132

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - SUPPL1

ER -